These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19625125)

  • 41. Duloxetine and Subacute Pain after Knee Arthroplasty when Added to a Multimodal Analgesic Regimen: A Randomized, Placebo-controlled, Triple-blinded Trial.
    YaDeau JT; Brummett CM; Mayman DJ; Lin Y; Goytizolo EA; Padgett DE; Alexiades MM; Kahn RL; Jules-Elysee KM; Fields KG; Goon AK; Gadulov Y; Westrich G
    Anesthesiology; 2016 Sep; 125(3):561-72. PubMed ID: 27387351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
    Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
    Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.
    Skljarevski V; Ossanna M; Liu-Seifert H; Zhang Q; Chappell A; Iyengar S; Detke M; Backonja M
    Eur J Neurol; 2009 Sep; 16(9):1041-8. PubMed ID: 19469829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V; Zhang S; Chappell AS; Walker DJ; Murray I; Backonja M
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder.
    Sheehan DV; Meyers AL; Prakash A; Robinson MJ; Swindle RW; Russell JM; Mallinckrodt CH
    Curr Med Res Opin; 2008 Sep; 24(9):2457-66. PubMed ID: 18662492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
    Demyttenaere K; Desaiah D; Petit C; Croenlein J; Brecht S
    Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
    Goldstein DJ; Lu Y; Detke MJ; Wiltse C; Mallinckrodt C; Demitrack MA
    J Clin Psychopharmacol; 2004 Aug; 24(4):389-99. PubMed ID: 15232330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-A randomized, double-blind, placebo-controlled, crossover study.
    Petersen KK; Drewes AM; Olesen AE; Ammitzbøll N; Bertoli D; Brock C; Arendt-Nielsen L
    Eur J Pain; 2022 Sep; 26(8):1650-1664. PubMed ID: 35638317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.
    Brunton S; Wang F; Edwards SB; Crucitti AS; Ossanna MJ; Walker DJ; Robinson MJ
    Drug Saf; 2010 May; 33(5):393-407. PubMed ID: 20397739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of duloxetine for postoperative pain after total knee arthroplasty in centrally sensitized patients: study protocol for a randomized controlled trial.
    Wang S; Wang W; Shao L; Ling J
    BMC Musculoskelet Disord; 2021 Mar; 22(1):316. PubMed ID: 33785016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
    J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta-analysis of randomised controlled trials.
    Chen L; Gong M; Liu G; Xing F; Liu J; Xiang Z
    Intern Med J; 2019 Dec; 49(12):1514-1523. PubMed ID: 30993832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.
    Shelton RC; Andorn AC; Mallinckrodt CH; Wohlreich MM; Raskin J; Watkin JG; Detke MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):348-55. PubMed ID: 17917553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Russell JW
    Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
    [No Abstract]   [Full Text] [Related]  

  • 60. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.